Stay updated on Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for AbbVie’s completed upadacitinib extension study is displayed, with its study details, results measures, eligibility criteria, locations, and documents, instead of a 403 error page.
    Difference
    100%
    Check dated 2026-11-11T02:10:17.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.2 to v3.8.0, while the study record remains inaccessible behind a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T00:50:19.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A sitewide NIH notice about a terminology transition was added, and the displayed site revision changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:51:58.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The site footer revision number changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-07T01:06:57.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Access to the study record now results in a 403 Forbidden error, replacing the study details with a standard error page. The page displays a 403 header and site footer.
    Difference
    18%
    Check dated 2026-09-23T00:55:55.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Platform revision updated from v3.6.6 to v3.7.0, indicating a portal/UI update rather than changes to the study details.
    Difference
    0.0%
    Check dated 2026-09-16T00:11:47.000Z thumbnail image

Stay in the know with updates to Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page.